Royalty Pharma plc (FRA:RPD)
Germany · Delayed Price · Currency is EUR 33.55
+0.41 (1.24%)
At close: Jan 30, 2026
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €14.99 billion as of January 30, 2026. Its market cap has increased by 12.92% in one year.
Market Cap
14.99B
Enterprise Value
24.43B
Revenue
2.00B
Ranking
n/a
PE Ratio
22.99
Stock Price
€33.55
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from 14.00B to 14.99B, an increase of 7.06%. That is a compound annual growth rate of 1.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 14.99B | 6.60% |
| Dec 31, 2025 | 14.06B | 28.43% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 886.48M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |